One major question remains at the center of the health care overhaul’s ultimate success or failure — and Democrats and Republicans have spent the past three years each swearing they know the answer.
Will the law cause insurance premiums to skyrocket, as Republicans vow, or will it slow costs down, as Democrats predict? And, for now, neither side has concrete evidence. We’ll get a better idea of who’s right soon, when insurers announce 2014 premiums later this year. Insurance companies must roll out plans by early fall, in time to bid in the new insurance exchanges — which must be open for shopping Oct. 1 — and to make employer-based coverage open-enrollment periods.
Read the full story: http://politi.co/XTiIvy
Source: Politico
Care Quality Metrics in Medicare During COVID-19 Pandemic
August 12th 2025Medicare Advantage outperformed traditional Medicare on clinical quality measures before and during the COVID-19 pandemic; mid-pandemic, however, traditional Medicare narrowed the gap on some in-person screenings.
Read More
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Care Quality Metrics in Medicare During COVID-19 Pandemic
August 12th 2025Medicare Advantage outperformed traditional Medicare on clinical quality measures before and during the COVID-19 pandemic; mid-pandemic, however, traditional Medicare narrowed the gap on some in-person screenings.
Read More
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
2 Commerce Drive
Cranbury, NJ 08512